you are here: Home News Cipla

Cipla

Neutral Cipla; target of Rs 1310: Motilal Oswal
Brokerage impact: Cipla falls on JPMorgan downgrade to 'neutral'; Syngene hits four-year low after Jefferies' downgrade
Cipla Consolidated December 2025 Net Sales at Rs 7,074.48 crore, up 0.02% Y-o-Y
Cipla Standalone December 2025 Net Sales at Rs 4,498.08 crore, down 9.51% Y-o-Y
Stocks to Watch Today: Tata Steel, Infosys, Gland Pharma, Cipla, HUDCO, Meesho, Adani Green, Angel One, Midwest in focus on 8 January
Cipla shares slide 4.5% after USFDA flags compliance gaps at key Lanreotide supplier site
Trade Spotlight: How should you trade Titan, Aditya Birla Sun Life AMC, Triveni Engineering, Tata Consumer Products, Emami, and others on December 17?
Stocks to Watch Today: Tata Steel, Ashoka Buildcon, Purvankara, Prestige Estates, Cipla, SBI Life Insurance, Luxury Time in focus on 11 December
Cipla Standalone September 2025 Net Sales at Rs 5,225.72 crore, up 9.44% Y-o-Y
Accumulate Cipla; target of Rs 1,620: Deven Choksey
Cipla Consolidated September 2025 Net Sales at Rs 7,589.44 crore, up 7.64% Y-o-Y
Data Story: Cipla shone under Umang Vohra, task cut out for new CEO
Accumulate Cipla; target of Rs 1675: Prabhudas Lilladher
Reduce Cipla; target of Rs 1580: Choice Equity Broking
Umang Vohra, Cipla’s outgoing CEO says task achieved, ‘not retiring’ from sector
Cipla says Achin Gupta to replace Umang Vohra as Cipla MD, global CEO from April 1; shares fall 4%
Cipla shares fall 3% after Eli Lilly deal to market weight-loss drug in India: Here's what analysts say
Hold Cipla; target of Rs 1570: Deven Choksey
Buy Cipla; target of Rs 1754: Mirae Asset Sharekhan
Trade Spotlight: How should you trade TCS, Exide Industries, Cipla, Max Financial Services, Hyundai Motor India, Nykaa, and others on August 26?
Trade Spotlight: How should you trade DMart, Can Fin Homes, Radico Khaitan, Cipla, Dr Reddys Labs, Caplin Point, Afcons Infra, and others on August 22?
Pharma stocks fall up to 2% as Trump threatens steep tariffs on drug imports
Buy Cipla; target of Rs 1800: ICICI Securities
Buy Cipla; target of Rs 1730: Prabhudas Lilladher
Trade Spotlight: How should you trade TCS, Cipla, Torrent Pharma, NCC, Paytm, SBI Life Insurance, UPL, Syrma SGS Technology and others on July 29?

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Cipla

Neutral Cipla; target of Rs 1310: Motilal Oswal

Brokerage impact: Cipla falls on JPMorgan downgrade to 'neutral'; Syngene hits four-year low after Jefferies' downgrade

Cipla Consolidated December 2025 Net Sales at Rs 7,074.48 crore, up 0.02% Y-o-Y

Cipla Standalone December 2025 Net Sales at Rs 4,498.08 crore, down 9.51% Y-o-Y

Stocks to Watch Today: Tata Steel, Infosys, Gland Pharma, Cipla, HUDCO, Meesho, Adani Green, Angel One, Midwest in focus on 8 January

Cipla shares slide 4.5% after USFDA flags compliance gaps at key Lanreotide supplier site

Trade Spotlight: How should you trade Titan, Aditya Birla Sun Life AMC, Triveni Engineering, Tata Consumer Products, Emami, and others on December 17?

Stocks to Watch Today: Tata Steel, Ashoka Buildcon, Purvankara, Prestige Estates, Cipla, SBI Life Insurance, Luxury Time in focus on 11 December

Cipla Standalone September 2025 Net Sales at Rs 5,225.72 crore, up 9.44% Y-o-Y

Accumulate Cipla; target of Rs 1,620: Deven Choksey

Cipla Consolidated September 2025 Net Sales at Rs 7,589.44 crore, up 7.64% Y-o-Y

Data Story: Cipla shone under Umang Vohra, task cut out for new CEO

Accumulate Cipla; target of Rs 1675: Prabhudas Lilladher

Reduce Cipla; target of Rs 1580: Choice Equity Broking

Umang Vohra, Cipla’s outgoing CEO says task achieved, ‘not retiring’ from sector

Cipla says Achin Gupta to replace Umang Vohra as Cipla MD, global CEO from April 1; shares fall 4%

Cipla shares fall 3% after Eli Lilly deal to market weight-loss drug in India: Here's what analysts say

Hold Cipla; target of Rs 1570: Deven Choksey

Buy Cipla; target of Rs 1754: Mirae Asset Sharekhan

Trade Spotlight: How should you trade TCS, Exide Industries, Cipla, Max Financial Services, Hyundai Motor India, Nykaa, and others on August 26?

Trade Spotlight: How should you trade DMart, Can Fin Homes, Radico Khaitan, Cipla, Dr Reddys Labs, Caplin Point, Afcons Infra, and others on August 22?

Pharma stocks fall up to 2% as Trump threatens steep tariffs on drug imports

Buy Cipla; target of Rs 1800: ICICI Securities

Buy Cipla; target of Rs 1730: Prabhudas Lilladher

Trade Spotlight: How should you trade TCS, Cipla, Torrent Pharma, NCC, Paytm, SBI Life Insurance, UPL, Syrma SGS Technology and others on July 29?